PMID: 16527002Mar 11, 2006Paper

Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis

Current Osteoporosis Reports
John P Bilezikian, Mishaela R Rubin

Abstract

In this paper, we focus upon the use of anabolic skeletal therapy for the treatment of postmenopausal and other forms of osteoporosis. The only anabolic skeletal agent currently available is a recombinant bioactive fragment of parathyroid hormone, PTH(1-34), known as teriparatide. The full length molecule, human PTH(1-84) is being investigated at this time as are other PTH molecules. Teriparatide improves bone quality by actions on bone turnover, bone density, bone size, and microarchitecture. In postmenopausal women with osteoporosis, teriparatide reduces the incidence for vertebral and nonvertebral fractures. In individuals who have been treated previously with an antiresorptive agent, the subsequent actions of teriparatide on bone density are delayed transiently if bone turnover is markedly suppressed. Combination therapy with teriparatide or PTH(1-84) and an antiresorptive does not appear, at this time, to offer advantages over the use of PTH or an antiresorptive alone. To maintain the gains in bone density with PTH, it is important to follow its use with an antiresorptive agent.

References

Feb 1, 1997·Skeletal Radiology·J SmithR H Spiro
May 14, 1999·The Journal of Clinical Endocrinology and Metabolism·D W DempsterJ P Bilezikian
May 10, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·N E LaneC D Arnaud
Jun 14, 2000·The Journal of Clinical Endocrinology and Metabolism·R S RittmasterC J Rosen
Jan 10, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·D B BurrJ M Hock
Feb 15, 2001·JAMA : the Journal of the American Medical Association·R LindsayE Seeman
May 9, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·F CosmanR Lindsay
Aug 11, 2001·Pharmaceutical Research·A Leone-BayR A Baughman
Oct 5, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·D W DempsterR Lindsay
Jul 5, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Armen H Tashjian, Bruce A Chabner
Sep 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Mishaela R Rubin, John P Bilezikian
Jan 4, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·E S OrwollG A Gaich
Jan 4, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Robert MarcusBruce Mitlak
Jan 4, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·M BetancourtR Vassilopoulou-Sellin
Feb 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Mara J HorwitzAndrew F Stewart
Feb 11, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·H J Häuselmann, R Rizzoli
Mar 7, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J R ZanchettaS L Myers
Sep 23, 2003·The New England Journal of Medicine·Dennis M BlackUNKNOWN PaTH Study Investigators
Sep 23, 2003·The New England Journal of Medicine·Joel S FinkelsteinRobert M Neer
Nov 7, 2003·The Journal of Clinical Endocrinology and Metabolism·Anthony B HodsmanRobert Lindsay
Nov 11, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Yebin JiangErik F Eriksen
Apr 8, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Bruce EttingerImre Pavo
Jun 4, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Etah S KurlandJohn P Bilezikian
Aug 24, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J-M KaufmanB H Mitlak
Dec 23, 2004·The Journal of Clinical Endocrinology and Metabolism·J Christopher GallagherJohn H Krege
Apr 21, 2005·The Journal of Clinical Endocrinology and Metabolism·Harald DobnigErik F Eriksen
May 11, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Peiqi ChenRachel B Wagman
Aug 2, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Richard PrinceBruce H Mitlak
Aug 2, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Camilo JimenezRobert F Gagel
Aug 12, 2005·The New England Journal of Medicine·Dennis M BlackUNKNOWN PaTH Study Investigators
Aug 12, 2005·The New England Journal of Medicine·Felicia CosmanRobert Lindsay
Aug 12, 2005·The New England Journal of Medicine·Clifford J Rosen
Aug 12, 2005·The New England Journal of Medicine·Robert P Heaney, Robert R Recker
Nov 22, 2005·Drugs·Mishaela R Rubin, John P Bilezikian

❮ Previous
Next ❯

Citations

Feb 27, 2007·Current Osteoporosis Reports·Luigi Gennari, John P Bilezikian
Feb 6, 2010·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J J StepanI Pavo
Sep 21, 2013·Current Osteoporosis Reports·Luigi Gennari, John P Bilezikian
Oct 20, 2006·Reviews in Endocrine & Metabolic Disorders·Jane B LianDaniel W Young
Apr 18, 2007·Current Rheumatology Reports·Luigi Gennari, John P Bilezikian
Sep 21, 2007·Der Internist·F Jakob
Apr 7, 2011·Current Medical Research and Opinion·Steven BoonenDirk Vanderschueren
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·Luigi Gennari, John P Bilezikian
Jan 23, 2008·Expert Opinion on Therapeutic Targets·Sengen Sun
Dec 7, 2007·American Journal of Obstetrics and Gynecology·Joann V Pinkerton, Alan C Dalkin
Dec 15, 2016·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·D L ManaJ R Zanchetta
Apr 8, 2014·Journal of Bone Metabolism·T John Martin
Jan 14, 2010·Clinical Pharmacokinetics·Teun M PostMeindert Danhof
Jan 20, 2018·Expert Opinion on Pharmacotherapy·Luigi Gennari, John P Bilezikian
Dec 13, 2018·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S LouY Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
J-M KaufmanB H Mitlak
Calcified Tissue International
John P Bilezikian, E S Kurland
© 2021 Meta ULC. All rights reserved